Tanvex BioPharma Revenue vs. Price To Sales
| 6541 Stock | TWD 72.30 6.20 9.38% |
For Tanvex BioPharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tanvex BioPharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tanvex BioPharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tanvex BioPharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tanvex BioPharma over time as well as its relative position and ranking within its peers.
Tanvex |
Tanvex BioPharma Price To Sales vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tanvex BioPharma's current stock value. Our valuation model uses many indicators to compare Tanvex BioPharma value to that of its competitors to determine the firm's financial worth. Tanvex BioPharma is rated fifth in revenue category among its peers. It is number one stock in price to sales category among its peers . The ratio of Revenue to Price To Sales for Tanvex BioPharma is about 7,929 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tanvex BioPharma's earnings, one of the primary drivers of an investment's value.Tanvex Revenue vs. Competition
Tanvex BioPharma is rated fifth in revenue category among its peers. Market size based on revenue of Biotechnology industry is presently estimated at about 16.63 Billion. Tanvex BioPharma adds roughly 5.41 Million in revenue claiming only tiny portion of stocks in Biotechnology industry.
Tanvex Price To Sales vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Tanvex BioPharma |
| = | 5.41 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Tanvex BioPharma |
| = | 681.78 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Tanvex Price To Sales Comparison
Tanvex BioPharma is currently under evaluation in price to sales category among its peers.
Tanvex BioPharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tanvex BioPharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tanvex BioPharma will eventually generate negative long term returns. The profitability progress is the general direction of Tanvex BioPharma's change in net profit over the period of time. It can combine multiple indicators of Tanvex BioPharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. TANVEX BIOPHARMA is traded on Taiwan Stock Exchange in Taiwan.
Tanvex Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tanvex BioPharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tanvex BioPharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tanvex BioPharma's important profitability drivers and their relationship over time.
Use Tanvex BioPharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tanvex BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tanvex BioPharma will appreciate offsetting losses from the drop in the long position's value.Tanvex BioPharma Pair Trading
Tanvex BioPharma Pair Trading Analysis
The ability to find closely correlated positions to Tanvex BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tanvex BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tanvex BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tanvex BioPharma to buy it.
The correlation of Tanvex BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tanvex BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tanvex BioPharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tanvex BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tanvex BioPharma position
In addition to having Tanvex BioPharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Restaraunts Hotels Motels Thematic Idea Now
Restaraunts Hotels Motels
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Restaraunts Hotels Motels theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaraunts Hotels Motels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.